Gbola Amusa
Director/Board Member bij RENOVACOR, INC.
Profiel
Gbola Amusa is Partner at Chardan Capital Markets LLC.
He is also on the board of Renovacor, Inc.
He previously was Head-European Pharma Research at Sanford Bernstein, Executive Chairman of BiomX Ltd., Executive Chairman at Chardan Healthcare Acquisition Corp., Executive Chairman & Chief Science Officer at Chardan Healthcare Acquisition 2 Corp., Associate of Goldman Sachs & Co. LLC, Analyst at UBS Ltd.
(Broker) and Analyst at Sanford C.
Bernstein Ltd.
He received an undergraduate degree from Duke University, an MBA from The University of Chicago Booth School of Business and a doctorate from Washington University School of Medicine.
Actieve functies van Gbola Amusa
Bedrijven | Functie | Begin |
---|---|---|
RENOVACOR, INC. | Director/Board Member | 02-09-2021 |
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Director of Research - Equity | 01-12-2014 |
Eerdere bekende functies van Gbola Amusa
Bedrijven | Functie | Einde |
---|---|---|
BIOMX INC. | Director/Board Member | 05-01-2023 |
CHARDAN HEALTHCARE ACQUISITION CORP | Chairman | 01-10-2019 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chairman | 01-10-2019 |
UBS Ltd. (Broker)
UBS Ltd. (Broker) Investment Banks/BrokersFinance UBS Ltd. (Broker) is the Great Britain-based brokerage division of UBS Ltd.,the wholly-owned subsidiary of Switzerland-based UBS AG (SWX: UBSN; NYSE: UBS). Established in 1975, the firm is located in London. UBS Ltd.'s business is organized in three departments: fixed-income, rates and currencies; equity and investment banking. UBS Ltd. (Broker) engages in equity trading, equity derivatives and equity-linked products. The equity research department covers a diverse range of sectors globally and also supplies macroeconomic analysis, quantitative and derivative research. The fixed-income, rates and currency business covers credit, rates, commodities including energy and metals, municipal bonds, Forex and cash and collateral trading globally. Their investment banking activities include analysis, structuring, transaction negotiation and communication. | Analyst-Equity | 01-03-2013 |
Sanford C. Bernstein Ltd.
Sanford C. Bernstein Ltd. Investment Banks/BrokersFinance Sanford C. Bernstein Ltd. is a securities brokerage firm headquartered in London, UK. They are a subsidiary of Alliancebernstein Corp. of Delaware, ultimately held by Equitable Holdings, Inc. (NYSE: EQH) in the US. Founded in 1999, the firm provides fundamental research and full service execution services to institutional clients globally. They offer bottom-up coverage and portfolio strategies supported by sophisticated quantitative tools. | Analyst-Equity | - |
Opleiding van Gbola Amusa
Duke University | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Washington University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOMX INC. | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
UBS Ltd. (Broker)
UBS Ltd. (Broker) Investment Banks/BrokersFinance UBS Ltd. (Broker) is the Great Britain-based brokerage division of UBS Ltd.,the wholly-owned subsidiary of Switzerland-based UBS AG (SWX: UBSN; NYSE: UBS). Established in 1975, the firm is located in London. UBS Ltd.'s business is organized in three departments: fixed-income, rates and currencies; equity and investment banking. UBS Ltd. (Broker) engages in equity trading, equity derivatives and equity-linked products. The equity research department covers a diverse range of sectors globally and also supplies macroeconomic analysis, quantitative and derivative research. The fixed-income, rates and currency business covers credit, rates, commodities including energy and metals, municipal bonds, Forex and cash and collateral trading globally. Their investment banking activities include analysis, structuring, transaction negotiation and communication. | Finance |
Sanford C. Bernstein Ltd.
Sanford C. Bernstein Ltd. Investment Banks/BrokersFinance Sanford C. Bernstein Ltd. is a securities brokerage firm headquartered in London, UK. They are a subsidiary of Alliancebernstein Corp. of Delaware, ultimately held by Equitable Holdings, Inc. (NYSE: EQH) in the US. Founded in 1999, the firm provides fundamental research and full service execution services to institutional clients globally. They offer bottom-up coverage and portfolio strategies supported by sophisticated quantitative tools. | Finance |
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Finance |
Sanford Bernstein | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Chardan Healthcare Acquisition Corp.
Chardan Healthcare Acquisition Corp. Financial ConglomeratesFinance Chardan Healthcare Acquisition Corp. is a blank check company, which engages in seeking and acquiring one or more growth businesses. It focuses on businesses that have their primary operations located in North America in the healthcare industry. The company was founded on November 1 , 2017 and is headquartered in New York, NY. | Finance |
Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. Financial ConglomeratesFinance Chardan Healthcare Acquisition 2 Corp. operates as a blank check company, which engages in the acquisition of healthcare company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |